Cycling Study With the Axonics System

Inclusion Criteria:

1. Participants who are ≥ 21 years at the time of consent

2. Has a primary indication of UUI (participants with a secondary indication of UF orFI may also be enrolled)

3. Has a diagnosis of UUI for greater than or equal to 6 months prior to the date ofconsent

4. UUI episodes:

5. For currently implanted participants (Group A), they must be considered therapyresponders with a >50% reduction in UUI episodes (based on their originalbaseline diaries) and satisfied with their SNM therapy

6. For de novo candidates (Group B), they must have completed a successful PNEdocumented with a >50% reduction in UUI episodes on a 3-day diary (a diary mustexist within a medical record or equivalent)

7. Willing and capable of providing informed consent

8. Agrees to return to the site for all study visits

9. Fluent (able to speak and read) in English

Exclusion Criteria:

1. Any participant that the study Investigator deems to be a poor candidate who isunable to complete a 72-hour bladder diary or will be non-compliant for study visits

2. Diagnosis of urinary retention

3. Surgical treatment for stress incontinence (e.g. sling, Burch), and/or pelvic organprolapse in the past 3 months or recommended or planned within 3 months from thetime of consent

4. Changes to current regimen of medications that could impact bladder function within 4 weeks prior to consent

5. Current urinary tract mechanical obstruction (e.g., benign prostatic enlargement orurethral stricture)

6. Current symptomatic urinary tract infection (UTI)

7. A patient who early discontinued from the ARTISTRY registry

8. A female with a positive urine pregnancy test

9. A female who is breastfeeding